Imaging assessment of bioresorbable vascular scaffolds-Reference-Cited by-同舟云学术

Imaging assessment of bioresorbable vascular scaffolds

Published:2017-08-01 Issue:1 Volume:33 Page:11-22
ISSN:1868-4300
Container-title:Cardiovascular Intervention and Therapeutics
language:en
Short-container-title:Cardiovasc Interv and Ther

Author:

Sotomi Yohei,Suwannasom Pannipa,Tenekecioglu Erhan,Collet Carlos,Nakatani Shimpei,Okamura Takayuki,Muramatsu Takashi,Ishibashi Yuki,Tateishi Hiroki,Miyazaki Yosuke,Asano Taku,Katagiri Yuki,von zur Muehlen Constantin,Tanabe Kengo,Kozuma Ken,Ozaki Yukio,Serruys Patrick W.,Onuma Yoshinobu

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s12928-017-0486-5/fulltext.html

Reference70 articles.

1. Serruys PW, Garcia-Garcia HM, Onuma Y. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J. 2012;33:16–25b.

2. Onuma Y, Serruys PW, Muramatsu T, Nakatani S, van Geuns RJ, de Bruyne B, et al. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2014;7:1400–11.

3. Nakatani S, Ishibashi Y, Sotomi Y, Perkins L, Eggermont J, Grundeken MJ, et al. Bioresorption and vessel wall integration of a fully bioresorbable polymeric everolimus-eluting scaffold: optical coherence tomography, intravascular ultrasound, and histological study in a porcine model with 4-year follow-up. JACC Cardiovasc Interv. 2016;9:838–51.

4. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202.

5. Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrie D, Piek JJ, et al. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet. 2016;388:2479–91.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CVIT 2023 clinical expert consensus document on intravascular ultrasound;Cardiovascular Intervention and Therapeutics;2023-09-01

2. Magnetic nanoparticle loaded biodegradable vascular stents for magnetic resonance imaging and long-term visualization;Journal of Materials Chemistry B;2023

3. Clinical expert consensus document on intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics (2021);Cardiovascular Intervention and Therapeutics;2021-11-12

4. Comparable neointimal healing in patients with stable coronary lesions and acute coronary syndrome: 3-month optical coherence tomography analysis;The International Journal of Cardiovascular Imaging;2021-02-16

5. Recent Least Burdensome Approach for the Approval of Innovative Medical Devices in Japan -Regulatory Approval Review of an Everolimus-eluting Bioresorbable Scaffold-;Internal Medicine;2021-01-15